Developed by US-based medical device company TheraBionic, the device was approved in September 2023 by the US Food and Drug ...
It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...
Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be ...
Dan G. Duda, DMD, Ph.D., of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback